Natco Pharma seeks approval for Molnupiravir capsules for Covid-19 treatment
American pharma major Merck along with Ridgeback Bio therapeutics has developed the drug26-04-2021
Natco Pharma seeks approval for Molnupiravir capsules for Covid-19 treatment
American pharma major Merck along with Ridgeback Bio therapeutics has developed the drugProcter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended March 31, 2021
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click hereMerck, partner halt covid-19 treatment trial for hospitalized patients
Companies to advance a separate study testing their oral antiviral drug in treating outpatients who are at high risk of complicationsProcter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by the shareholder, about the loss /misplacement of the share certificate as detailed in the attachment.Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 012120 Name of the Signatory :- Flavia MachadoDesignation :- Any OtherProcter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018 for the period January - March 2021.Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from April 1, 2021 until 48 hours from the publication of the unaudited financial results for quarter ended March 31, 2021. Kindly take the same on record.Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agent, KFin Technologies Private Limited about the issue of duplicate share certificates as detailed in the attachment.Coronavirus LIVE: India cases at 11,139,323; Merck to help make J&J; vaccine
Coronavirus live updates: Over 5 million people have registered themselves on the Co-WIN portal since Monday. Stay tuned for corona-related newsProcter & Gamble Health Ltd - 500126 - Related Party Transactions For Six Months Ended December 31, 2020
We are enclosing herewith the Related Party Transactions for six months ended December 31, 2020. Kindly take the same on record and oblige.